Clec1b: A Protein Targeted for Cancer and Other Diseases (G51266)

Target Name: CLEC1B

NCBI ID: G51266

CLEC1B

Clec1b: A Protein Targeted for Cancer and Other Diseases

clec1b, also known as PRO1384, is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a crucial role in cellular signaling.

Members of the GPCR family include many different proteins that are expressed in different tissues and organs. clec1b is one of them. clec1b is a protein that is expressed in various tissues such as the human brain, heart, and kidneys. It is a member of the GPCR family, which plays an important role in cell signaling.

In recent years, researchers have studied more and more clec1b. Research shows that clec1b plays an important role in many physiological processes. For example, clec1b plays an important role in neuronal development and function. Studies have shown that clec1b is related to neuronal apoptosis, and the loss of clec1b can lead to neuronal apoptosis. In addition, clec1b is also closely related to heart disease and kidney disease.

clec1b has also received attention as a drug target. Researchers are exploring whether clec1b could serve as a potential drug target to treat certain diseases. For example, clec1b has been used as a drug target to treat some cancers, and some researchers are exploring whether clec1b could serve as a drug target to treat other diseases.

clec1b has important research value as a drug target. It can be used as a potential drug target to treat cancer and other diseases, providing new ideas and directions for medical research.

Protein Name: C-type Lectin Domain Family 1 Member B

Functions: C-type lectin-like receptor that functions as a platelet receptor for the lymphatic endothelial marker, PDPN (PubMed:18215137). After ligand activation, signals via sequential activation of SRC and SYK tyrosine kinases leading to activation of PLCG2 (PubMed:18955485)

The "CLEC1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLEC1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets